NCT01108809 - Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients | Biotech Hunter

Enrollment

295

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

January 31, 2011

Conditions

Hypertension

Interventions

DRUG

Telmisartan or Telmisartan and Hydrochlorthiazide

Telmisartan 80mg +/- Hydrochlorthiazide 12.5mg or 25mg

Trial Locations (49)

Unknown

Boehringer Ingelheim Investigational Site 1, Arad

Boehringer Ingelheim Investigational Site 5, Bacau

Boehringer Ingelheim Investigational Site 6, Baia Mare

Boehringer Ingelheim Investigational Site 9, Brasov

Boehringer Ingelheim Investigational Site 8, Brăila

Boehringer Ingelheim Investigational Site 10, Bucharest

Boehringer Ingelheim Investigational Site 11, Bucharest

Boehringer Ingelheim Investigational Site 12, Bucharest

Boehringer Ingelheim Investigational Site 13, Bucharest

Boehringer Ingelheim Investigational Site 14, Bucharest

Boehringer Ingelheim Investigational Site 15, Bucharest

Boehringer Ingelheim Investigational Site 16, Bucharest

Boehringer Ingelheim Investigational Site 17, Bucharest

Boehringer Ingelheim Investigational Site 18, Bucharest

Boehringer Ingelheim Investigational Site 19, Bucharest

Boehringer Ingelheim Investigational Site 20, Bucharest

Boehringer Ingelheim Investigational Site 21, Bucharest

Boehringer Ingelheim Investigational Site 22, Bucharest

Boehringer Ingelheim Investigational Site 23, Buzău

Boehringer Ingelheim Investigational Site 4, Campulung Muscel

Boehringer Ingelheim Investigational Site 42, Carei

Boehringer Ingelheim Investigational Site 24, Călăraşi

Boehringer Ingelheim Investigational Site 26, Cluj-Napoca

Boehringer Ingelheim Investigational Site 27, Cluj-Napoca

Boehringer Ingelheim Investigational Site 28, Cluj-Napoca

Boehringer Ingelheim Investigational Site 29, Constanța

Boehringer Ingelheim Investigational Site 31, Craiova

Boehringer Ingelheim Investigational Site 2, Curtea de Argeş

Boehringer Ingelheim Investigational Site 38, Drobeta-Turnu Severin

Boehringer Ingelheim Investigational Site 32, Galati

Boehringer Ingelheim Investigational Site 34, Iași

Boehringer Ingelheim Investigational Site 35, Iași

Boehringer Ingelheim Investigational Site 36, Iași

Boehringer Ingelheim Investigational Site 37, Iași

Boehringer Ingelheim Investigational Site 7, Oradea

Boehringer Ingelheim Investigational Site 3, Piteşti

Boehringer Ingelheim Investigational Site 40, Ploieşti

Boehringer Ingelheim Investigational Site 41, Ploieşti

Boehringer Ingelheim Investigational Site 49, Râmnicu Vâlcea

Boehringer Ingelheim Investigational Site 25, Reşiţa

Boehringer Ingelheim Investigational Site 33, Slobozia

Boehringer Ingelheim Investigational Site 43, Suceava

Boehringer Ingelheim Investigational Site 30, Târgovişte

Boehringer Ingelheim Investigational Site 39, Târgu Mureş

Boehringer Ingelheim Investigational Site 44, Timișoara

Boehringer Ingelheim Investigational Site 45, Timișoara

Boehringer Ingelheim Investigational Site 46, Timișoara

Boehringer Ingelheim Investigational Site 47, Timișoara

Boehringer Ingelheim Investigational Site 48, Tulcea